S. Perl

Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia

R. Terkeltaub, V. Perkovic, H. Heerspink, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Elevated Uric Acid Prevalence and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from RELAX.

M. Roe, Jie-Lena Sun, A. Carnicelli, 2020, The American journal of medicine.

Goodpasture's (anti-GBM) disease and HLA-DRw2.

G. Macdonald, B. Pussell, J. Charlesworth, 1981, The New England journal of medicine.

Calcified adrenals associated with perinatal adrenal hemorrhage and adrenal insufficiency.

N. Patronas, C. Stratakis, M. Keil, 2007, The Journal of clinical endocrinology and metabolism.

Insufficiency Calcified Adrenals Associated with Perinatal Adrenal Hemorrhage and Adrenal

N. Patronas, C. Stratakis, M. Keil, 2007 .

Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment

N. Iqbal, B. Hirshberg, W. Cook, 2016, Diabetes Therapy.

Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout.

Neha J. Pagidipati, M. Roe, N. Pagidipati, 2020, The American journal of cardiology.

Triple therapy with low‐dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetes

J. Rosenstock, S. Jacob, R. García-Sánchez, 2019, Diabetes, obesity & metabolism.

Effects of Glimepiride versus Saxagliptin on β-Cell Function and Hypoglycemia: A Post Hoc Analysis in Older Patients with Type 2 Diabetes Inadequately Controlled with Metformin.

B. Hirshberg, P. Ohman, W. Cook, 2016, Clinical therapeutics.

Reduced cardiac beat-to-beta variation in chronic renal failure: a ubiquitous marker of autonomic neuropathy.

E. Kraegen, Z. Endre, G. Macdonald, 1982, Clinical science.

Verinurad does not prolong QTc interval: a thorough QT study using concentration–QTc modelling

C. Gottfridsson, J. Parkinson, C. Dota, 2022, British Journal of Clinical Pharmacology.

Urate‐lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink

M. Bjursell, S. Perl, S. Kiddle, 2024, Clinical cardiology.

Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical Trial.

D. Kitzman, A. Voors, S. Perl, 2024, JAMA cardiology.